Dashboard
1
With a growth in Net Sales of 2.9%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 12 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 22.54 MM
- NET PROFIT(HY) Higher at USD 2.19 MM
- NET SALES(Q) Highest at USD 78.05 MM
2
Risky -
3
Rising Promoter Confidence
4
Underperformed the market in the last 1 year
Stock DNA
Computers - Software & Consulting
USD 872 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.91
-999,999.00%
4.01
Revenue and Profits:
Net Sales:
78 Million
(Quarterly Results - Mar 2026)
Net Profit:
-3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
45.11%
0%
45.11%
6 Months
-4.86%
0%
-4.86%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Omada Health, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
41.82%
EBIT Growth (5y)
29.77%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
82.31%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.01
EV to EBIT
-30.13
EV to EBITDA
-39.55
EV to Capital Employed
35.98
EV to Sales
2.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-119.41%
ROE (Latest)
-10.30%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 21 Schemes (19.08%)
Foreign Institutions
Held by 35 Foreign Institutions (4.87%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
78.00
75.80
2.90%
Operating Profit (PBDIT) excl Other Income
-3.30
4.70
-170.21%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.00
5.20
-157.69%
Operating Profit Margin (Excl OI)
-61.30%
43.30%
-10.46%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.90% vs 11.47% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -157.69% vs 262.50% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
260.20
169.80
53.24%
Operating Profit (PBDIT) excl Other Income
-6.50
-38.90
83.29%
Interest
2.50
4.50
-44.44%
Exceptional Items
-3.60
0.20
-1,900.00%
Consolidate Net Profit
-12.80
-47.10
72.82%
Operating Profit Margin (Excl OI)
-46.00%
-257.10%
21.11%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 53.24% vs 38.27% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 72.82% vs 30.22% in Dec 2024






